Fountain syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3219OMIM:229120Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fountain syndrome is an extremely rare genetic disorder first described by R.B. Fountain in 1974. It is characterized by the combination of intellectual disability, deafness (sensorineural hearing loss), skeletal abnormalities, and a distinctive facial appearance with full, rounded cheeks and thick lips due to subcutaneous edema or swelling of the soft tissues. The condition affects multiple body systems including the central nervous system, the auditory system, the skeletal system, and the integumentary system. Key clinical features include moderate to severe intellectual disability, sensorineural deafness, coarse facial features with thickened subcutaneous tissue (particularly of the face and hands), and skeletal anomalies such as short stature and thickened calvaria (skull bones). Some patients may also exhibit seizures and hand abnormalities including stubby, swollen fingers. The facial swelling is thought to result from an abnormal accumulation of subcutaneous connective tissue or edematous changes. Fountain syndrome is exceedingly rare, with only a handful of cases reported in the medical literature. There is no specific cure or targeted treatment available. Management is supportive and symptomatic, focusing on educational support for intellectual disability, hearing aids or cochlear implants for hearing loss, and seizure management with anticonvulsant medications when needed. Multidisciplinary care involving geneticists, audiologists, neurologists, and developmental specialists is recommended.

Also known as:

Clinical phenotype terms— hover any for plain English:

Craniofacial hyperostosisHP:0004493
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Fountain syndrome.

View clinical trials →

No actively recruiting trials found for Fountain syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fountain syndrome community →

No specialists are currently listed for Fountain syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fountain syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fountain syndromeForum →

No community posts yet. Be the first to share your experience with Fountain syndrome.

Start the conversation →

Latest news about Fountain syndrome

No recent news articles for Fountain syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Fountain syndrome

What is Fountain syndrome?

Fountain syndrome is an extremely rare genetic disorder first described by R.B. Fountain in 1974. It is characterized by the combination of intellectual disability, deafness (sensorineural hearing loss), skeletal abnormalities, and a distinctive facial appearance with full, rounded cheeks and thick lips due to subcutaneous edema or swelling of the soft tissues. The condition affects multiple body systems including the central nervous system, the auditory system, the skeletal system, and the integumentary system. Key clinical features include moderate to severe intellectual disability, sensori

How is Fountain syndrome inherited?

Fountain syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Fountain syndrome typically begin?

Typical onset of Fountain syndrome is childhood. Age of onset can vary across affected individuals.